AVITA Medical, Inc. (RCEL) SEC Filings & Earnings Calls

Dependence on Stedical for commercialization; minimum growth commitments may pressure margins if sales underperform.

“20% growth minimums each year through 2030” · word for word

Cash runway limited; $11.1M cash with path to breakeven in Q4 but execution risk remains

“Cash, cash equivalents, and marketable securities at the end of the quarter of approximately $11.1 million” · word for word

Dependence on CMS reimbursement for RECELL; proposed 2027 rules positive but not final

“CMS released proposed calendar year 2027 Medicare payment updates for RECELL that, if adopted, would set national physician payment”

Going concern uncertainty

“Based on our liquidity position and current forecast of operating results and cash flows, management determined there is substantial doubt about our ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements, due to our debt repayment obligations, historical negative cash flows” · word for word

Debt covenant compliance risk

“This credit facility also establishes trailing twelve-month revenue covenants aligned with our current operating trajectory, including $68.5 million for the quarter ended March 31, 2026, $69.0 million for the quarter ended June 30, 2026, and $73.0 million for the year ending December 31, 2026”

Reimbursement dependency

“Delay by the MACs in establishing and publishing reimbursement rates temporarily slowed clinician use of RECELL” · word for word

Potential dilution from warrant exercise.

“Warrant covers up to 650,000 shares at $3.4019.”

Cash burn elevated in Q1 due to timing; cash position $14.3M relatively low.

“Net cash use of approximately $9.9 million in the quarter... The Company ended the quarter with approximately $14.3 million in cash and marketable securities” · word for word

Gross margin declined from 84.7% to 81.7% due to product mix shift.

“Gross profit margin was 81.7%, compared to 84.7% in the prior-year period, reflecting product mix and inventory-related adjustments.” · word for word

Going concern risk

“Based on the Company’s liquidity position and the Company’s current forecast of operating results and cash flows, management determined there is substantial doubt about the Company’s ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to the Company’s debt repayment ” · word for word

Debt covenant compliance risk

“The Credit Agreement includes a financial maintenance test that requires us to maintain a specified minimum net revenue for each trailing twelve-month period ending on the last day of a fiscal quarter occurring prior to the maturity date of the Loan Facility with the first such test occurring as of the fiscal quarter ended March 31, 2026.” · word for word

Shareholder approval risk for warrants

“Additionally, our failure to obtain Warrant Shareholder Approval on or prior to November 30, 2026 shall constitute an event of default under the Credit Agreement.” · word for word

Executive transition risk; new CEO may change strategy or face integration challenges.

“CEO transition from interim to permanent; new employment agreement with severance terms.”

Debt covenant compliance risk

“Failure to meet minimum net revenue covenants could trigger an Event of Default, accelerating repayment obligations.”

Going concern risk

“management determined there is substantial doubt about our ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to our debt repayment obligations, historical negative cash flows, and recurring losses.” · word for word

Debt covenant risk

“if the Company’s net revenue does not equal or exceed a certain amount for upcoming fiscal periods as set forth in the Perceptive Credit Agreement, then the Company will be in default of the Perceptive Credit Agreement.” · word for word

Revenue concentration risk

“We are executing a focused commercial strategy centered on approximately 200 U.S. burn and trauma centers” · word for word

Reimbursement headwinds persist but are easing; six of seven MACs have published rates.

“Six of seven MACs have published payment rates for RECELL, further removing a key constraint on utilization.”

Gross margin pressure from product mix and inventory adjustments.

“Gross profit margin was 81.2% versus 87.6% in Q4 2024, reflecting product mix and inventory-related adjustments.” · word for word

Revenue covenant risk under new credit facility requires Q1 2026 revenue of $15.4M, which may be challenging given Q4 2025 revenue of $17.6M and seasonal patterns.

“the Company will be required to achieve $15.4 millon in revenue in the first quarter 2026.” · word for word

Clinical trial data readouts in 2026 carry binary risk; failure could impact growth narrative.

“data from both clinical studies expected later in 2026.” · word for word

Revenue guidance cut by ~8% at midpoint signals demand weakness.

“FY2025 revenue guidance lowered to $70-74M from $76-81M.”

Credit agreement amendment with added principal indicates financial strain.

“Added $500K to principal for covenant waiver; Q4 revenue covenant reset to $70M.”

Reimbursement transition and hospital VAC reviews create near-term uncertainty.

“Delayed clinician reimbursement transitions for RECELL; pace of hospital VAC reviews for Cohealyx.”

Going concern uncertainty

“These events and conditions raise substantial doubt about our ability to continue as a going concern.” · word for word

Debt covenant non-compliance

“We were not in compliance with the trailing 12-month net revenue covenants for the first and second quarters of 2025.” · word for word

Reimbursement headwind

“The decrease in commercial revenues was primarily driven by Medicare Administrative Contractor (MAC) reimbursement headwinds.” · word for word